Chompers are back. Run back to highs., page-49

I always get a wry smile when i see the optimistic seller at the bottom of the depth list who regularly puts their hand up to sell their shares at $20.00 per share.
I believe we could be worth that much given time, and a bit of competitive tension. However, I get the feeling we will look back at this in 10 years time and say, "I can't believe we only sold Cynata for $3.80 back in 2019! Of course, Fujifilm then having the MSC market wrapped up and making $10B a year off the back of the Cymerus tech.
With 800 odd MSC trials in the pipeline we are using our tech on 3 of them... Surely our IP protection is such now that we can give trial companies free access to Cymerus, getting in at the ground floor of the approvals process. Maybe once we have the sub-licencing issue with WARF sorted out we may be able to move towards this model.